United States · Series B startup

Who invested in Aerami Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$5.4Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $5.4MSept 2022
Investors
0
See who backed them

The rounds

  1. Sept 2022
    Series B$5.4M

    No investor was named in the report.

    Source recordedSEC filing: $5.4M sold, first sale Oct 2022

Quick answers about Aerami Therapeutics

How much has Aerami Therapeutics raised?

Aerami Therapeutics has raised $5.4M across 1 round since 2022.

When did Aerami Therapeutics last raise?

Aerami Therapeutics's most recent round was a Series B of $5.4M in Sept 2022.

What was Aerami Therapeutics's biggest round?

Its most recent round, $5.4M in Sept 2022, is also its largest on record.

What stage is Aerami Therapeutics at?

Aerami Therapeutics's latest named round is a Series B, in Sept 2022.

Where is Aerami Therapeutics based?

Aerami Therapeutics is based in the United States.

Companies like Aerami Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.